Multilocus sequence typing of serially collected isolates of cryptococcus from HIV-infected patients in South Africa

Journal of Clinical Microbiology

Volumn 52, Issue 6, 2014, Pages 1921-1931

  Van Wyk, Marelize ^a   Govender, Nelesh P ^a,b   Mitchell, Thomas G ^c   Litvintseva, Anastasia P ^c  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; DNA; FLUCONAZOLE;

ADOLESCENT; ADULT; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CHILD; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; DNA ISOLATION; FEMALE; FUNGAL STRAIN; FUNGUS ISOLATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PLOIDY; PRIORITY JOURNAL; REINFECTION; RELAPSE; SCHOOL CHILD; SEQUENCE ANALYSIS; SOUTH AFRICA; CLASSIFICATION; CLUSTER ANALYSIS; COMPLICATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; MENINGITIS, CRYPTOCOCCAL; MICROBIOLOGY; MIDDLE AGED; RECURRENT DISEASE; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CLUSTER ANALYSIS; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; FEMALE; GENETIC VARIATION; GENOTYPE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; RECURRENCE; SOUTH AFRICA; YOUNG ADULT;

EID: 84901652303     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03177-13     Document Type: Article

References (37)

1. Lin X, Heitman J. 2006. The biology of the Cryptococcus neoformans species complex. Annu. Rev. Microbiol. 60:69-105. http://dx.doi.org/10.1146/ annurev.micro.60.080805.142102. (Pubitemid 44627941)
2. Perfect JR. 2007. Management of cryptococcosis: how are we doing? PLoS Med. 4:e47. http://dx.doi.org/10.1371/journal.pmed.0040047.
3. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen MH, Pappas PG, Powderly WG, Singh N, Sobel JD, Sorrell TC. 2010. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 50:291-322. http://dx.doi.org/10.1086/649858.
4. Mitchell TG, Casta?eda E, Nielsen K, Wanke B, Laz?ra MS. 2011. Ecological niches for Cryptococcus neoformans and C. gattii, p 237-259. In Heitman J, Kozel TR, Kwon-Chung KJ, Perfect JR, Casadevall A (ed), Cryptococcus: from human pathogen to model yeast. ASM Press, Washington, DC.
5. Park BJ, Wannemuehler KA, Marston BJ, Govender NP, Pappas PG, Chiller TM. 2009. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23:525-530. http://dx.doi.org/10.1097/QAD. 0b013e328322ffac.
6. Lessells RJ, Mutevedzi PC, Heller T, Newell M-L. 2011. Poor long-term outcomes for cryptococcal meningitis in rural South Africa. S. Afr. Med. J. 101:251-252.
7. Jarvis JN, Dromer F, Harrison TS, Lortholary O. 2008. Managing cryptococcosis in the immunocompromised host. Curr. Opin. Infect. Dis. 21:596-603. http://dx.doi.org/10.1097/QCO.0b013e3283177f6c.
8. Jarvis JN, Meintjes GA, Williams Z, Rebe K, Harrison TS. 2010. Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: the role of inadequate secondary prophylaxis. S. Afr. Med. J. 100: 378-382.
9. Shelburne SA, III, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC, Jr, Hamill RJ. 2005. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 19:399-406. http://dx.doi.org/10.1097/01.aids.0000161769.06158.8a. (Pubitemid 40446186)
10. McCarthy KM, Meintjes GA, Arthington-Skaggs BA, Bicanic T, Chiller TM, Cotton MP, Govender NP, Harrison TS, Karstaedt AS, Maartens G, Varavia E, Venter F, Vismer HF. 2007. Guidelines for the diagnosis, management and prevention of cryptococcal meningitis and disseminated cryptococcosis in HIV-infected patients. South. Afr. J. HIV Med. 8:25-35.
11. Govender NP. 2009. Trends in antifungal drug susceptibility of Cryptococcus species in South Africa, 2002-2008, p 201. Abstr. EP-01-5. 17th Congress of the International Society for Human and Animal Mycology, Tokyo, Japan.
12. Govender NP, Mitchell TG, Litvintseva AP, Miglia KJ. 2011. Cryptococcosis in Africa, p 269-285. In Heitman J, Kozel TR, Kwon-Chung KJ, Perfect JR, Casadevall A (ed), Cryptococcus: from human pathogen to model yeast. ASM Press, Washington, DC.
13. Park BJ, Shetty S, Ahlquist AM, Greenbaum A, Miller JL, Motsi A, McCarthy KM, Govender NP; Gauteng Cryptococcal Surveillance Initiative Group. 2011. Long-term follow-up and survival of antiretroviral-naive patients with cryptococcal meningitis in the preantiretroviral therapy era, Gauteng Province, South Africa. Int. J. STD AIDS 22:199-203. http://dx.doi.org/10.1258/ijsa.2010. 010235.
14. Litvintseva AP, Xu J, Mitchell TG. 2011. Population structure and ecology of Cryptococcus neoformans and C. gattii, p 97-111. In Heitman J, Kozel TR, Kwon-Chung KJ, Perfect JR, Casadevall A (ed), Cryptococcus: from human pathogen to model yeast. ASM Press, Washington, DC.
15. Meyer W, Aanensen DM, Boekhout T, Cogliati M, Diaz MR, Esposto MC, Fisher MC, Gilgado F, Hagen F, Kaocharoen S, Litvintseva AP, Mitchell TG, Simwami SP, Trilles L, Viviani MA, Kwon-Chung KJ. 2009. Consensus multilocus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med. Mycol. 47:561-570. http://dx.doi.org/10.1080/13693780902953886.
16. Mitchell TG, Litvintseva AP. 2010. Typing species of Cryptococcus and epidemiology of cryptococcosis, p 167-190. In Ashbee HR, Bignell EM (ed), Pathogenic yeasts. Springer-Verlag, Berlin Heidelberg, Germany.
17. Kwon-Chung KJ, Polacheck I, Bennett JE. 1982. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J. Clin. Microbiol. 15:535-537. (Pubitemid 12178899)
18. Litvintseva AP, Thakur R, Vilgalys RJ, Mitchell TG. 2006. Multilocus sequence typing reveals three genetic subpopulations of Cryptococcus neoformans var. grubii (serotype A), including a unique population in Botswana. Genetics 172:2223-2238. http://dx.doi.org/10.1534/genetics.105.046672.
19. Litvintseva AP, Carbone I, Rossouw J, Thakur R, Govender NP, Mitchell TG. 2011. Evidence that the human-pathogenic fungus Cryptococcus neoformans var. grubii may have evolved in Africa. PLoS One 6:e19688. http://dx.doi.org/10.1371/ journal.pone.0019688.
20. Litvintseva AP, Kestenbaum L, Vilgalys RJ, Mitchell TG. 2005. Comparative analysis of environmental and clinical populations of Cryptococcus neoformans. J. Clin. Microbiol. 43:556-564. http://dx.doi.org/10.1128/JCM.43.2.556-564.2005. (Pubitemid 40256000)
21. Litvintseva AP, Marra RE, Nielsen K, Heitman J, Vilgalys RJ, Mitchell TG. 2003. Evidence of sexual recombination among Cryptococcus neoformans serotype A isolates in sub-Saharan Africa. Eukaryot. Cell 2:1162-1168. http://dx.doi.org/10.1128/EC.2.6.1162-1168.2003. (Pubitemid 38047226)
22. Lin X, Patel S, Litvintseva AP, Floyd A, Hicks R, Mitchell TG, Heitman J. 2009. Diploids in the Cryptococcus neoformans serotype A population homozygous for the- mating type originate via unisexual mating. PLoS Pathog. 5:e1000283. http://dx.doi.org/10.1371/journal.ppat.1000283.
23. Govender NP, Patel J, van Wyk M, Chiller TM, Lockhart SR, Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa (GERMS-SA). 2011. Trends in antifungal drug susceptibility of Cryptococcus neoformans obtained through population-based surveillance, South Africa, 2002-2003 and 2007-2008. Antimicrob. Agents Chemother. 55:2606-2611. http://dx.doi.org/10.1128/AAC.00048-11.
24. Espinel-Ingroff A, Aller AI, Cant?n E, Castanon-Olivares LR, Chowdhary A, Cordoba S, Cuenca-Estrella M, Fothergill AW, Fuller JA, Govender NP, Hagen F, Ilnait Zaragozi MT, Johnson E, Kidd SE, Lass-Fl?rl C, Lockhart SR, Martins MA, Meis JFGM, Melhem MSC, Ostrosky-Zeichner L, Pel?ez T, Pfaller MA, Schell WA, St Germain G, Trilles L, Turnidge J. 2012. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole and voriconazole. Antimicrob. Agents Chemother. 56:5898-5906. http://dx.doi.org/10.1128/AAC.01115-12.
25. Miglia KJ, Govender NP, Rossouw J, Meiring ST, Mitchell TG; Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa. 2011. Analysis of pediatric isolates of Cryptococcus neoformans from South Africa. J. Clin. Microbiol. 49:307-314. http://dx.doi.org/10.1128/JCM.01277-10.
26. Litvintseva AP, Mitchell TG. 2012. Population genetic analyses reveal the African origin and strain variation of Cryptococcus neoformans var. grubii. PLoS Pathog. 8:e1002495. http://dx.doi.org/10.1371/journal.ppat.1002495.
27. Desnos-Ollivier M, Patel S, Spaulding AR, Charlier C, Garcia-Hermoso D, Nielsen K, Dromer F. 2010. Mixed infections and in vivo evolution in the human fungal pathogen Cryptococcus neoformans. mBio 1:e00091-10. http://dx.doi.org/10. 1128/mBio.00091-10.
28. Govender NP. 2007. HIV-associated opportunistic fungal infections: a guide to using the clinical microbiology laboratory. South. Afr. J. HIV Med. 8:18-23.
29. Boulware DR, Meya DB, Bergemann TL, Wiesner DL, Rhein J, Musubire AK, Lee SJ, Kambugu A, Janoff EN, Bohjanen PR. 2010. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. PLoS Med. 7:e1000384. http://dx.doi.org/10.1371/journal.pmed.1000384.
30. Pfaller MA, Messer SA, Boyken LB, Rice C, Tendolkar S, Hollis RJ, Doern GV, Diekema DJ. 2005. Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004). J. Clin. Microbiol. 43: 2163-2167. http://dx.doi.org/10.1128/JCM.43.5.2163-2167.2005. (Pubitemid 40656221)
31. Xu J, Onyewu C, Yoell HJ, Ali RY, Vilgalys RJ, Mitchell TG. 2001. Dynamic and heterogeneous mutations to fluconazole resistance in Cryptococcus neoformans. Antimicrob. Agents Chemother. 45:420-427. http://dx.doi.org/10.1128/ AAC.45.2.420-427.2001. (Pubitemid 32105275)
32. Sionov E, Chang YC, Garraffo HM, Kwon-Chung KJ. 2009. Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence. Antimicrob. Agents Chemother. 53:2804-2815. http://dx.doi.org/10. 1128/AAC.00295-09.
33. Sionov E, Chang YC, Kwon-Chung KJ. 2013. Azole heteroresistance in Cryptococcus neoformans: emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment. Antimicrob. Agents Chemother. 57:5127-5130. http://dx.doi.org/10.1128/AAC.00694-13.
34. Chen J, Varma A, Diaz MR, Litvintseva AP, Wollenberg KK, Kwon-Chung KJ. 2008. Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China. Emerg. Infect. Dis. 14:755-762. http://dx.doi.org/10.3201/eid1405.071312. (Pubitemid 351838639)
35. Choi YH, Ngamskulrungroj P, Varma A, Sionov E, Hwang S-M, Carriconde F, Meyer W, Litvintseva AP, Lee WG, Shin JH, Kim EC, Lee KW, Choi TY, Lee YS, Kwon-Chung KJ. 2010. Prevalence of the VNIc genotype of Cryptococcus neoformans in non-HIV-associated cryptococcosis in the Republic of Korea. FEMS Yeast Res. 10:769-778. http://dx.doi.org/10.1111/j.1567-1364.2010.00648.x.
36. Simwami SP, Khayhan K, Henk DA, Aanensen DM, Boekhout T, Hagen F, Brouwer AM, Harrison TS, Donnelly CA, Fisher MC. 2011. Low diversity Cryptococcus neoformans variety grubii multilocus sequence types from Thailand are consistent with an ancestral African origin. PLoS Pathog. 7:e1001343. http://dx.doi.org/ 10.1371/journal.ppat.1001343.
37. Umeyama T, Ohno H, Minamoto F, Takagi T, Tanamachi C, Tanabe K, Kaneko Y, Yamagoe S, Kishi K, Fujii T, Takemura H, Watanabe H, Miyazaki Y. 2013. Determination of epidemiology of clinically isolated Cryptococcus neoformans strains in Japan by multilocus sequence typing. Jpn. J. Infect. Dis. 66:51-55. http://dx.doi.org/10.7883/yoken.66.51.